Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients

Completed · Not applicable

Conditions studied: Asthma, Asthma in Children

In brief

This is a multi-center study to evaluate fractional exhaled nitric oxide (FeNO) measured with the Vivatmo pro in adult and pediatric subjects.

Key facts

Study ID

NCT04450108

Run by

Bosch Healthcare Solutions GmbH

People needed

122

Starts

2020-09-08

Expected to finish

2021-04-13

Last updated by the study team

2022-06-06

Who can join

Age: 7 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subject is 7 to 80 years of age.
• Has asthma
• Has been identified as a candidate for inhaled corticosteroid (ICS) treatment
• Is willing and able to perform Vivatmo pro™ testing

You may not qualify if…

• Subject has used corticosteroids prior to enrollment.
• Subject has other current serious medical conditions
• Subject has not been clinically stable for at least 2 weeks prior to the study
• Subject is unwilling or unable to perform Vivatmo pro testing

Where it is running

• Clinical Research Center of Alabama — Birmingham, Alabama, United States
• Kern Research, Inc. — Bakersfield, California, United States
• Chesapeake Clinical Research, Inc. — White Marsh, Maryland, United States
• The Clinical Research Center, LLC — St Louis, Missouri, United States
• North Carolina Clinical Research — Raleigh, North Carolina, United States
• Allergy Asthma Research Institute — Waco, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.